新型约束性髋臼装置的中期生存率
本研究回顾性分析了177例使用Freedom Constrained髋臼内衬的病例,平均随访7.1年。结果显示7年全因生存率74.8%,无菌生存率83.6%,不稳定性生存率91.8%;
要点
- 约束性内衬中期无菌生存率83.6%,但全因生存率仅74.8%。
- 活动性不稳患者脱位失败率显著高于风险患者(15.2% vs 3%)。
- 感染失败率10.7%,其中58%有既往感染史。
核心结论
- 约束性内衬是处理全髋关节置换术后不稳定的选项,但复发率仍较高。
- 翻修不稳定性仍具挑战性,因患者多经历多次手术且存在高风险解剖结构。
研究设计与样本
- 纳入177例随访至少2年或失败的患者,平均既往手术3.4次。
- 手术类型:130例无菌翻修,40例感染清除后再植入,7例复杂初次置换。
- 约束机制植入原因:46髋(26%)为治疗活动性不稳,131髋(74%)为增加不稳风险或术中不稳。
主要发现
- 平均随访7.1年,11髋(6.2%)脱位,13髋(7.3%)因髋臼无菌性松动翻修,总体约束无菌或机械失败率13.6%。
关键数值与推荐
- 7年全因生存率74.8%,无菌生存率83.6%,不稳定性生存率91.8%。
临床怎么用
- 对于全髋置换后反复不稳且解剖条件差的患者,可考虑使用约束性内衬。
- 术前应告知活动性不稳患者脱位复发风险较高。
- 有既往感染史的患者使用约束性内衬需警惕感染失败风险。
局限性
- 回顾性研究设计。
- 单中心、单器械结果。
- 未设置对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recurrent instability after total hip arthroplasty is a difficult complication. In certain cases, a constrained acetabular device is needed to address these issues. The purpose of this study is to report the midterm outcomes and survivorship of a single novel constrained liner device. METHODS: A retrospective review as performed on all procedures (except first stage exchange for infection) in which a Freedom Constrained (Zimmer Biomet, Warsaw, IN) liner was used between December 2003 and November 2016. Patients with 2-year minimum follow-up or failure were included, yielding a cohort of 177 patients. Procedures were 130 aseptic revisions, 40 reimplantations following infection eradication, and 7 complex primaries. The constrained mechanism was implanted in 46 hips (26%) to treat active instability and 131 hips (74%) for increased risk of instability and intraoperative instability. Patients had on average 3.4 previous surgeries. RESULTS: With an average 7.1-year follow-up, 11 hips dislocated (6.2%), and 13 hips (7.3%) were revised for acetabular aseptic loosening, resulting in an overall constrained aseptic or mechanical failure rate of 13.6%. Nineteen hips (10.7%) failed from infection with 58% of these having had a previous infection. Patients with active instability had significantly higher failure for dislocation than patients who were at risk (15.2% vs 3%, P = .01). All-cause survival rate at 7 years was 74.8%, aseptic survival was 83.6%, and survival for instability was 91.8%. CONCLUSION: Revision for instability remains challenging as many patients have had numerous previous surgeries and at-risk anatomy. Constrained inserts are one option to manage instability, but a high rate of recurrence can still occur.
引用
- Crawford DA, Adams JB, Brown KW, et al. Mid-Term Survivorship of a Novel Constrained Acetabular Device. J Arthroplasty. 2019. PMID: 31668696. doi:10.1016/j.arth.2019.09.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。